The study looks at periodic fasting before chemotherapy and how that alters tumor metabolism and sensitivity to drugs. Metabolism shapes how cancer grows and survives, and changing when the body receives fuel can create a different chemical environment inside tumors. That environment may make cancer cells more vulnerable to chemotherapy while leaving normal cells better able to cope with stress.
For patients and families, the most interesting question is whether an approach like controlled fasting could be safe, affordable, and add meaningful benefit to standard care. The implications reach beyond treatment into quality of life and access to therapies. Read the full article to see how these findings connect to broader efforts to expand human potential, reduce disparities in cancer care, and design treatments that fit real lives.
A simple change in meal timing may help improve outcomes for women with the most common and aggressive form of ovarian cancer, a new study suggests. “Despite advancements in surgery and chemotherapy, patients with advanced ovarian cancer still face poor outcomes,” said lead…
